Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Activity tracker to prescribe various exercise intensities in breast cancer survivors
McNeil J, Brenner DR, Stone CR, O'Reilly R, Ruan Y, Vallance JK, Courneya KS, Thorpe KE, Klein DJ, Friedenreich CM
Medicine and Science in Sports and Exercise 2019 May;51(5):930-940
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

PURPOSE: To prescribe different physical activity (PA) intensities using activity trackers to increase PA, reduce sedentary time and improve health outcomes among breast cancer survivors. The maintenance effect of the interventions on study outcomes was also assessed. METHODS: The Breast Cancer and Physical Activity Level (BC-PAL) pilot trial randomized 45 breast cancer survivors to a home-based, 12-week lower (300 minutes/week at 40 to 59% of heart rate reserve) or higher (150 minutes/week at 60 to 80% of heart rate reserve) intensity PA, or no PA intervention/control. Both intervention groups received Polar A360 activity trackers. Study outcomes assessed at baseline, 12- and 24-weeks included PA and sedentary time (ActiGraph GT3X+), health-related fitness (eg body composition, cardiopulmonary fitness/VO2max) and patient-reported outcomes (eg quality of life). Intention-to-treat analyses were conducted using linear mixed models and adjusted for baseline outcomes. RESULTS: Increases in moderate-vigorous intensity PA (least squares adjusted group difference (LSAGD) 0.6 (95% confidence interval (CI) 0.1 to 1.0)) and decreases in sedentary time (LSAGD -1.2 (95% CI -2.2 to -0.2)) were significantly greater in the lower intensity PA group versus control at 12-weeks. Increases in VO2max at 12-weeks in both interventions groups were significantly greater than changes in the control group (lower intensity PA group LSAGD 4.2 (95% CI 0.5 to 8.0 ml/kg/min); higher intensity PA group LSAGD 5.4 (95% CI 1.7 to 9.1 ml/kg/min)). Changes in PA and VO2max remained at 24-weeks, but differences between the intervention and control groups were no longer statistically significant. CONCLUSION: Increases in PA time and cardiopulmonary fitness/VO2max can be achieved with both lower- and higher-intensity PA interventions in breast cancer survivors. Reductions in sedentary time were also noted in the lower intensity PA group.

Full text (sometimes free) may be available at these link(s):      help